undamentalytics Newsletter
Sign in

Envoy Medical, Inc. income statement

In fiscal 2025, Envoy Medical, Inc. reported revenue of $241,000, up 7.1% on the year before, operating income of −$22.3m (a -9240.7% margin) and net income of −$23.8m, or −$1.23 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue00000
Cost of revenue01111
Gross profit−0−0−1−1−1
Research and development59101214
Selling, general and administrative37———
Selling and marketing——211
General and administrative——788
Operating income−9−18−19−22−24
Interest expense——12—
Income before tax21—−21−24—
Income tax2————
Net income−16−30−21−24−23
Diluted EPS−$1.57−$2.54−$1.49−$1.23−$0.42
Diluted shares (average)10m12m19m23m56m
EBITDA−9−18−19−22−23

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: COCH vs NXLCOCH vs QTEXCOCH vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Envoy Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envoy Medical, Inc.